PGR and neoplasm: The prognostic performance of the AI model demonstrated hazard ratios comparable to those of RS across clinical subgroups, including menopausal status, tumor grade, tumor size, PR status, and treatment, as measured by distant recurrence-free interval (Figure 2d).